Publications by authors named "Jay Traverse"

Claim this Profile
C
Cardiotropic AAV gene therapy for heart failure: a phase 1 trial.
Timothy D Henry, Eugene S Chung, Monica Alvisi, Ferzin Sethna, David R Murray, Jay H Traverse

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Artificial Intelligence Detected Features on the ECG and Presence of Microvascular Obstruction.
Jay H Traverse, H Pendell Meyers, Adam Rafadjus, Scott W Sharkey, Sarah Schwager

Circ Cardiovasc Interv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
Paige E Carlson, Sarah Schwager, Katianna Feldewerd, Stephanie Schmidt, Michelle Campbell, Jay H Traverse

Int J Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
Paige E Carlson, Sarah Schwager, Katianna Feldewerd, Stephanie Schmidt, Michelle Campbell, Jay H Traverse

Int J Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD.
Jordan B Strom, Brandon M Herbert, Marnie Bertolet, Maria M Brooks, Shahbaz A Malik, Jay H Traverse

J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial.
Sunil V Rao, Maria Mori Brooks, Helen E A D'Agostino, P Gabriel Steg, Tabassome Simon, Jay H Traverse

Circ Cardiovasc Interv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia.
Gerard T Portela, Gregory Ducrocq, Marnie Bertolet, John H Alexander, Shaun G Goodman, Jay H Traverse

Am Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of long-term mortality in patients with ST-segment elevation myocardial infarction is dictated by the presence of microvascular obstruction.
Giselle Fisher, Brynn Okeson, Evan Walser-Kuntz, Joao L Cavalcante, Jay H Traverse

Eur Heart J Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
Kenta Nakamura, Timothy D Henry, Jay H Traverse, David A Latter, Nahush A Mokadam

Circ Cardiovasc Interv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supersaturated Oxygenation: Impact on Microvascular Obstruction?
Timothy D Henry, Saraschandra Vallabhajosyula, Jay H Traverse

J Soc Cardiovasc Angiogr Interv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Pressure-Controlled Intermittent Coronary Sinus Occlusion in STEMI: The Road Not Taken!
Jay H Traverse

Circ Cardiovasc Interv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing landscape of cardiac co-morbidities and in-hospital cardiac complications mediating Covid-19 mortality between 2020 and 2021.
Thomas R Basala, Marissa E Dulas, Alexis Albers, Sara D Olson, Brynn Okeson, Jay H Traverse

Am Heart J Plus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXACT Trial: Results of the Phase 1 Dose-Escalation Study.
Thomas J Povsic, Timothy D Henry, Jay H Traverse, R David Anderson, Geoffrey A Answini

Circ Cardiovasc Interv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, treatment and outcomes of coronary artery dissection during percutaneous coronary intervention.
Elizabeth Page, Spyridon Kostantinis, Judit Karacsonyi, Salman S Allana, Evan Walser-Kuntz, Jay H Traverse

J Invasive Cardiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarction.
Sarah J Davidson, Jerome Roncalli, Daniel Surder, Roberto Corti, Atul R Chugh, Jay H Traverse

Am Heart J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI.
Anna C Gonzalez Griffin, Mehmet Yildiz, Steven Bradley, Jenna E Smith, Santiago Garcia, Jay Traverse

Catheter Cardiovasc Interv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian dependence of microvascular obstruction during ST-segment elevation myocardial infarction.
Nicole L Bonfig, Chase R Soukup, Ananya A Shah, Sarah J Davidson, Larissa I Stanberry, Jay H Traverse

Int J Cardiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
Bahadir Simsek, Spyridon Kostantinis, Judit Karacsonyi, Salman Allana, Evangelia Vemmou, Jay Traverse

Catheter Cardiovasc Interv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction.
Nicole L Bonfig, Chase R Soukup, Ananya A Shah, Susan Olet, Sarah J Davidson, Jay H Traverse

Am J Physiol Heart Circ Physiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When should patients with acute myocardial infarction undergo CABG? A question much in need of a randomized clinical trial?
Jay H Traverse

Int J Cardiol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use.
Doris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, Mariana Gonzalez Del Hierro, Emerson C Perin, Jay H Traverse

Cardiovasc Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Treatment, and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention.
Vennela Avula, Judit Karacsonyi, Spyridon Kostantinis, Bahadir Simsek, Bavana V Rangan, Jay H Traverse

J Invasive Cardiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
Bahadir Simsek, Spyridon Kostantinis, Judit Karacsonyi, Evangelia Vemmou, Ilias Nikolakopoulos, Jay Traverse

Catheter Cardiovasc Interv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dare to dream? Cell-based therapies for heart failure after DREAM-HF: Review and roadmap for future clinical study.
Peter V Johnston, Amish N Raval, Timothy D Henry, Jay H Traverse, Carl J Pepine

Am Heart J Plus· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial.
Lourdes Chacon Alberty, Emerson C Perin, James T Willerson, Amir Gahremanpour, Roberto Bolli, Jay H Traverse

Front Cardiovasc Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis